Often identified by the words "believe," "expect,"Įxpressions, including the negative thereof. The United States Securities Act of 1933, as amended (the "SecuritiesĪct"), and Section 21E of the United States Securities Exchange Act ofġ934, as amended (the "Exchange Act"). Limitation statements regarding the conversion and trading of Ordinary SharesĪnd ADSs, are forward-looking statements within the meaning of Section 27A of Statements of historical fact contained in this announcement, including without You are recommended to read this document alongsideĬontains "forward-looking statements." All statements other than ![]() In respect of the conversion of ordinary shares to ADSs, and does not purport to be a statement of theĪpproaches or steps a person should take in evaluating whether or not to convert their ordinary shares. Not, and is not intended to, constitute a recommendation regarding any decision ![]() Regarding the listing of ADSs on Nasdaq, are set out in theĪvailable on 4D's website. Full details of the Merger and its terms, as well as information Not, and does not purport to be, a comprehensive overview of the Merger and its ![]() Useful information regarding 4D pharma’s listing of Americans Depositary Shares (ADSs) on NASDAQĭocument is for information only in connection with the listing of ADSs on Nasdaq. (Longevity), a Nasdaq-listed special purpose acquisition company (SPAC), and 4D pharma American Depositary Shares (ADSs) began trading on the Nasdaq Global Market (Nasdaq) under ticker symbol ' LBPS'.ĤD pharma ordinary shares continue to be admitted to trading on AIM under the ticker ' DDDD'.Īs declared effective by the United States Securities and Exchange Commission (SEC) On 22 March 2021, 4D pharma completed its business combination with Longevity Acquisition Corp. Admission of 4D pharma American Depositary Shares (ADSs) to trading on Nasdaq
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |